Linked e-resources
Details
Table of Contents
Section I. History, Epidemiologic Background and Pathogenesis of Coronavirus
Chapter 01: Surfaces as a source for SARS-CoV-2 transmission
Chapter 02: Humoral immune response in SARS-CoV-2 infection & its therapeutic relevance
Chapter 03: SARS-CoV-2 Invasion and Pathogenesis of COVID-19: A Perspective of viral receptors, bradykinin and purinergic system
Chapter 04: Genetics and Biological characteristics of SARS-CoV-2
Chapter 05: COVID-19 impact on host at pathophysiological and cellular level
Chapter 06: Identification of the COVID-19 droplet deposition path and its effects on the human respiratory tract before and after the disease: A scoping novel respiratory mask design
Chapter 07: SARS-CoV-2 variants: Impact of Spike Mutations on Vaccine and Therapeutic strategies
Chapter 08: Global biologic characteristics of Variants of Concern and Variants of Interest of SARS-CoV-2
Chapter 09: Emergence of COVID-19 variants and its global impact
Section II. Clinical Observations
Chapter 10: Psychological Impacts of the COVID-19 Pandemic
Chapter 11: Spatial Epidemiology of COVID-19: Disease Risk, Prognosis, and Complications
Chapter 12: Eye disorders and neuro-ophthalmic manifestations of COVID-19
Chapter 13: Evaluation and Management of Dysphagia during the COVID-19 Pandemic
Chapter 14: Gastrointestinal Manifestations Of COVID-19, and Inflammatory Bowel Disease in the COVID-19 Era, Clinical Overview And Updated Guidelines
Chapter 15: Post COVID-19 conditions-the new challenge to mankind
Chapter 16: Association of Alpha 1 Antitrypsin deficiency with COVID-19 mortality: basis for clinical trials
Chapter 17: Social cognition approaches to understanding and changing COVID-19 preventive behaviours
Chapter 18: Neurological Complications of COVID-19
Chapter 19: The Impact of Covid-19 on Surgical Disease
Section III. Interventions and Treatments
Chapter 20: Pre-Hospital Management of COVID-19: Looking for a Future Perspective
Chapter 21: Biotechnological strategies in the intervention and treatment of COVID-19
Chapter 22: Vitamin D: A Potential Prophylactic and Therapeutic Agent against COVID-19
Section IV. Current Trends and Future Directions
Chapter 23: Rational repurposing of drugs, clinical trials candidates, and natural products for SARS-Cov-2 therapy
Chapter 24: In Silico Drug Repositioning for COVID-19: Progress and Challenges
Chapter 25: Computationally Repurposed Natural Products Targeting SARS-CoV-2 Attachment and Entry Mechanisms
Chapter 26: Different platforms, immune response modulators and challenges in SARS-CoV-2 vaccination
Chapter 27: SARS-CoV-2 vaccine against virus: mission accomplished !?
Chapter 28: COVID-19 vaccines authorized by stringent regulatory authorities and vaccine candidates expecting approval in 2021
Chapter 29: The Global Evolution of Clinical Practice During a Pandemic
Chapter 30: Anticipated Long-Term Neurobehavioral Outcomes following COVID-19
Chapter 31. The road ahead.
Chapter 01: Surfaces as a source for SARS-CoV-2 transmission
Chapter 02: Humoral immune response in SARS-CoV-2 infection & its therapeutic relevance
Chapter 03: SARS-CoV-2 Invasion and Pathogenesis of COVID-19: A Perspective of viral receptors, bradykinin and purinergic system
Chapter 04: Genetics and Biological characteristics of SARS-CoV-2
Chapter 05: COVID-19 impact on host at pathophysiological and cellular level
Chapter 06: Identification of the COVID-19 droplet deposition path and its effects on the human respiratory tract before and after the disease: A scoping novel respiratory mask design
Chapter 07: SARS-CoV-2 variants: Impact of Spike Mutations on Vaccine and Therapeutic strategies
Chapter 08: Global biologic characteristics of Variants of Concern and Variants of Interest of SARS-CoV-2
Chapter 09: Emergence of COVID-19 variants and its global impact
Section II. Clinical Observations
Chapter 10: Psychological Impacts of the COVID-19 Pandemic
Chapter 11: Spatial Epidemiology of COVID-19: Disease Risk, Prognosis, and Complications
Chapter 12: Eye disorders and neuro-ophthalmic manifestations of COVID-19
Chapter 13: Evaluation and Management of Dysphagia during the COVID-19 Pandemic
Chapter 14: Gastrointestinal Manifestations Of COVID-19, and Inflammatory Bowel Disease in the COVID-19 Era, Clinical Overview And Updated Guidelines
Chapter 15: Post COVID-19 conditions-the new challenge to mankind
Chapter 16: Association of Alpha 1 Antitrypsin deficiency with COVID-19 mortality: basis for clinical trials
Chapter 17: Social cognition approaches to understanding and changing COVID-19 preventive behaviours
Chapter 18: Neurological Complications of COVID-19
Chapter 19: The Impact of Covid-19 on Surgical Disease
Section III. Interventions and Treatments
Chapter 20: Pre-Hospital Management of COVID-19: Looking for a Future Perspective
Chapter 21: Biotechnological strategies in the intervention and treatment of COVID-19
Chapter 22: Vitamin D: A Potential Prophylactic and Therapeutic Agent against COVID-19
Section IV. Current Trends and Future Directions
Chapter 23: Rational repurposing of drugs, clinical trials candidates, and natural products for SARS-Cov-2 therapy
Chapter 24: In Silico Drug Repositioning for COVID-19: Progress and Challenges
Chapter 25: Computationally Repurposed Natural Products Targeting SARS-CoV-2 Attachment and Entry Mechanisms
Chapter 26: Different platforms, immune response modulators and challenges in SARS-CoV-2 vaccination
Chapter 27: SARS-CoV-2 vaccine against virus: mission accomplished !?
Chapter 28: COVID-19 vaccines authorized by stringent regulatory authorities and vaccine candidates expecting approval in 2021
Chapter 29: The Global Evolution of Clinical Practice During a Pandemic
Chapter 30: Anticipated Long-Term Neurobehavioral Outcomes following COVID-19
Chapter 31. The road ahead.